Approval

Lupin Receives Approval for Meloxicam Capsules

Mumbai, June 02, 2020: Pharma major Lupin Limited (Lupin) announced that it has received approval for its Meloxicam Capsules, 5 mg…

5 years ago

Lupin Receives Approval for Trientine Hydrochloride Capsules USP

Mumbai, May 26, 2020: Pharma major Lupin Limited (Lupin) announced that it has received approval for its Trientine Hydrochloride Capsules USP,…

5 years ago

Lincoln Pharmaceuticals Ltd receives European Union (EU) GMP approval

To soon enter the EU markets with its Dermatology, Gastro and Pain Management products and expand gradually  Highlights:- ·         EU permission will increase…

5 years ago

Lincoln Pharmaceuticals Ltd receives approval to manufacture Hydroxychloroquine and Hydroxychloroquine Sulfate Tablets to fight COVID19

New Delhi, April 29, 2020: Lincoln Pharmaceuticals Limited, one of India's leading healthcare companies has received approval to manufacture Hydroxychloroquine (HCQ)…

5 years ago

Cadila Pharma accredited as Authorized Economic Operator

Cadila Pharmaceuticals  recognized as the Authorized Economic Operator (AEO) by the Central Board of Indirect Taxes and Customs. Ahmedabad, July…

5 years ago

Dr. Reddy’s Laboratories announces the launch of Ramelteon Tablets, in the U.S. Market

Hyderabad, July 23, 2019: Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DR REDDY, NYSE: RDY, along with its subsidiaries together…

5 years ago

Eisai’s Anticancer Agent Halaven Approved for Treatment of Locally Advanced or Metastatic Breast Cancer in China

Tokyo, July 17, 2019: Eisai has received a New Drug Approval for its in-house developed anticancer agent Halaven (eribulin mesylate)…

5 years ago

Dr. Reddy’s Laboratories announces entering into a definitive agreement to sell its neurology branded products to Upsher-Smith Laboratories, LLC

Hyderabad, June 14, 2019: Dr. Reddy's Laboratories Limited (BSE: 500124, NSE: DRREDDY, NYSE: RDY), announces that it has entered into…

6 years ago

Lupin’s Pithampur Unit-3 (Indore) receives EIR from USFDA

Mumbai, April 18, 2019: Pharma major Lupin Limited (Lupin) today announced the receipt of the Establishment Inspection Report (EIR) for its…

6 years ago

Wockhardt Receives US FDA Approval for Prostate cancer drug

New Delhi, March 07, 2019: Pharmaceutical and biotechnology major Wockhardt has received approval from the United States Food & Drug Administration…

6 years ago